Zobrazeno 1 - 10
of 123
pro vyhledávání: '"Tibor M. Brunt"'
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 23, p 14747 (2022)
The recreational use of nitrous oxide (N2O) has increased over the years. At the same time, more N2O intoxications are presented to hospitals. The incidental use of N2O is relatively harmless, but heavy, frequent and chronic use comes with considerab
Externí odkaz:
https://doaj.org/article/3710467e2e8143a5a6bce0d548d1a0e5
Autor:
Tibor M. Brunt, Wim van den Brink, Jan van Amsterdam, Cleo L. Crunelle, Filipa Raposo Pereira
Publikováno v:
Current Neuropharmacology. 20:809-819
Background: GHB (gamma-hydroxybutyric acid; sodium oxybate) is a general anaesthetic that is clinically used for the treatment of narcolepsy, cataplexy, alcohol withdrawal and alcohol relapse prevention. In addition, GHB is recreationally used. Most
Publikováno v:
Neurotoxicity Research
Although MDMA (ecstasy) is a relatively safe recreational drug and is currently considered for therapeutic use for the treatment of posttraumatic stress disorder (PTSD) and alcohol use disorder (AUD), recreational MDMA use occasionally elicits hypert
Autor:
Matthijs G. Bossong, Tibor M. Brunt
Publikováno v:
European Journal of Neuroscience. 55:909-921
The endocannabinoid system is a complex neuronal system involved in a number of biological functions, like attention, anxiety, mood, memory, appetite, reward, and immune responses. It is at the centre of scientific interest, which is driven by therap
Publikováno v:
Therapeutic drug monitoring, 42(2), 271-281. Lippincott Williams and Wilkins
Background The novel phenethylamines 4-fluoroamphetamine (4-FA) and 2,5-dimethoxy-4-bromophenethylamine (2C-B) fall in the top 10 most used new psychoactive substances (NPSs) among high-risk substance users. Various phenethylamines and NPS are also h
Publikováno v:
Therapeutic Drug Monitoring, 42, 75-82
Therapeutic drug monitoring, 42(1), 75-82. Lippincott Williams and Wilkins
Therapeutic Drug Monitoring, 42, 1, pp. 75-82
Therapeutic drug monitoring, 42(1), 75-82. Lippincott Williams and Wilkins
Therapeutic Drug Monitoring, 42, 1, pp. 75-82
Contains fulltext : 214516.pdf (Publisher’s version ) (Closed access) Purpose: Substance use disorder often coexists with other psychiatric disorders, resulting in the simultaneous use of recreational and prescription drugs. The authors aimed to id
Autor:
Elodie Lefrancois, Volker Auwärter, Denise A. McKeown, Jozsef Csorba, Sara Karolak, Anne Arponen, Teemu Gunnar, Tibor M. Brunt, Victor Detrez, Daniel Deimel, Jürgen Kempf, Thomas Seyler, Anneke E. Goudriaan, Thomas Nefau, Andrew McAuley
Publikováno v:
International journal on drug policy, 95:103130. Elsevier
BASE-Bielefeld Academic Search Engine
BASE-Bielefeld Academic Search Engine
Background and aims Injecting drug use is a matter of public health concern, associated with risks of overdoses, addiction and increased risk of bloodborne viral transmissions. Self-reported data on substances injected can be inaccurate or subject to
Publikováno v:
Addiction (Abingdon, England)References. 117(2)
Autor:
Johannes G. Ramaekers, Magí Farré, Patricia Robledo, Eulàlia Olesti, Tibor M. Brunt, Rafael de la Torre, Ilario De Toma, Marcel·li Carbó, Cristina Fernández-Avilés, Oscar J. Pozo, Mara Dierssen
Publikováno v:
Recercat. Dipósit de la Recerca de Catalunya
instname
Journal of Psychopharmacology, 33(3), 347-354. SAGE Publications Ltd
Journal of Psychopharmacology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Journal of psychopharmacology (Oxford, England), 33(3), 347-354. SAGE Publications Ltd
instname
Journal of Psychopharmacology, 33(3), 347-354. SAGE Publications Ltd
Journal of Psychopharmacology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Journal of psychopharmacology (Oxford, England), 33(3), 347-354. SAGE Publications Ltd
Background: The unprecedented proliferation of new psychoactive substances (NPS) threatens public health and challenges drug policy. Information on NPS pharmacology and toxicity is, in most cases, unavailable or very limited and, given the large numb